Skip to main content
. 2020 Sep 29;10:573822. doi: 10.3389/fonc.2020.573822

Figure 1.

Figure 1

The secretion levels of IL-6, IL-2R, TNF-α, and IL-8 in the anti-CD19-CAR T-cell therapy. The peaks of the cytokines were on days 4–7 post infusion of anti-CD19-CAR T-cells, and the levels then declined 14 days post infusion. (A) The secretion levels of IL-6 in the anti-CD19-CAR T-cell therapy. (B) The secretion levels of IL-8 in the anti-CD19-CAR T-cell therapy. (C) The secretion levels of IL-2R in the anti-CD19-CAR T-cell therapy. (D) The secretion levels of TNF-a in the anti-CD19-CAR T-cell therapy.